Tylenol w/ codeine no. 3 and Hearing loss - a phase IV clinical study of FDA data

Summary:

Hearing loss is reported as a side effect among people who take Tylenol w/ codeine no. 3 (acetaminophen; codeine phosphate), especially for people who are female, 50-59 old, also take Paxil, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Hearing loss when taking Tylenol w/ codeine no. 3. It is created by eHealthMe based on reports of 4,453 people who have side effects when taking Tylenol w/ codeine no. 3 from the FDA, and is updated regularly.

What is Tylenol w/ codeine no. 3?

Tylenol w/ codeine no. 3 has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 4,920 Tylenol w/ codeine no. 3 users. Check the latest studies of Tylenol w/ codeine no. 3.

What is Hearing loss?

Hearing loss is found to be associated with 1,351 drugs and 2,377 conditions by eHealthMe. Check the latest studies of Hearing loss.

On May, 21, 2026

4,453 people reported to have side effects when taking Tylenol w/ codeine no. 3.
Among them, 27 people (0.61%) have Hearing loss.

Could Tylenol w/ codeine no. 3 cause Hearing loss?

Among these 27 people:

What is the gender of people who have Hearing loss when taking Tylenol w/ codeine no. 3? *

female: 92.59 %
male: 7.41 %

What is the age of people who have Hearing loss when taking Tylenol w/ codeine no. 3? *

What are other drugs people take besides Tylenol w/ codeine no. 3? *

What are other side effects people have besides Hearing loss? *

Coronary Heart Disease (narrowing or blockage of the coronary arteries): 17 people, 62.96%
Infection: 17 people, 62.96%
Thrombocytopenia (decrease of platelets in blood): 17 people, 62.96%
Peripheral Vascular Disorder: 17 people, 62.96%
Swelling Face: 17 people, 62.96%
Swallowing Difficulty: 17 people, 62.96%
Pulmonary Congestion (congestion in the lungs): 17 people, 62.96%
Pain In Jaw: 17 people, 62.96%
Cardiac Disorder: 17 people, 62.96%
X-Ray Abnormal: 16 people, 59.26%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 59.26%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 16 people, 59.26%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 12 people, 44.44%
Depression: 4 people, 14.81%
Pelvic Pain: 3 people, 11.11%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 3.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.70%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 3.70%
Migraine (headache): 1 person, 3.70%
Joint Pain: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tylenol w/ codeine no. 3 and have Hearing loss?

- Check whether Hearing loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tylenol w/ codeine no. 3:

Tylenol w/ codeine no. 3 (4,920 reports)

Hearing loss treatments and more:

Hearing loss (30,352 reports)

How severe was Hearing loss and when was it recovered:

Hearing loss in Tylenol w/ codeine no. 3

Expand to all the drugs that have ingredients of acetaminophen; codeine phosphate:

Hearing loss and drugs with ingredients of acetaminophen; codeine phosphate (99 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tylenol w/ codeine no. 3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hearing loss:

Hearing loss (1,351 drugs)

Browse all the conditions that are associated with Hearing loss:

Hearing loss (2,377 conditions)

Related publications that referenced our studies

Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; codeine phosphate (the active ingredients of Tylenol w/ codeine no. 3) and Tylenol w/ codeine no. 3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.